AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $645,000 | -5.1% | 61,738 | -2.5% | 0.01% | +7.7% |
Q2 2022 | $680,000 | -6.1% | 63,290 | -17.3% | 0.01% | +18.2% |
Q1 2022 | $724,000 | -23.1% | 76,484 | -6.1% | 0.01% | -15.4% |
Q4 2021 | $941,000 | +19.0% | 81,481 | -1.6% | 0.01% | +8.3% |
Q3 2021 | $791,000 | -1.5% | 82,826 | -0.6% | 0.01% | 0.0% |
Q2 2021 | $803,000 | +3.2% | 83,326 | +5.8% | 0.01% | 0.0% |
Q1 2021 | $778,000 | -26.0% | 78,752 | +72.8% | 0.01% | -29.4% |
Q4 2020 | $1,052,000 | +405.8% | 45,571 | +210.1% | 0.02% | +325.0% |
Q3 2020 | $208,000 | +74.8% | 14,697 | +86.3% | 0.00% | +100.0% |
Q2 2020 | $119,000 | – | 7,889 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |